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Attacks of Familial Mediterranean fever (FMF) represent
one of the most devastating states of inflammation. FMF
is an autoinflammatory disease caused by mutations in
the gene coding for pyrin. We aimed to assess the charac-
teristics of inflammation in FMF patients during an acute
attack by evaluating some growth factors, chemokines and
cytokines.
Six patients (median 11 years (7–16)) were sampled 12–
36 hour after the onset of a typical FMF attack. All had ele-
vated acute phase reactants. All six had homozygote muta-
tions in the MEFV gene. Various cytokines, chemokines,
growth factors and CD40 ligand were measured by a com-
mercially available multiplex beads immunoassay based
on Luminex platform. IL1Ra (median 1047 pg/ml), TNF
alpha (median 3.05 pg/ml) and IL6 (median 19.14 pg/
ml) levels were elevated whereas IL2, IL10, IL12, IL17 and
IL13 were not detectable in any of the samples. EGF, VEGF
and HGF were markedly elevated as well. Among the
chemokines, MIP1b, CCL11, CXCL11 and CXCL5 were all
detectable at a varying range. CD40 L was also markedly
elevated.
IL1Ra is induced by inflammatory stimuli with IL1 and
reflects the IL1-dependent inflammatory response. Chem-
okines were elevated reflecting the neutrophil inflamma-
tion and recruiting in this disease. The growth factors were
thought to be elevated as an inflammatory response phe-
nomena. The CD40L induction may be serving as a link
between the innate immune response and adaptive on
during the attacks of FMF.
The protein fingerptint of FMF will shed light on the
pathogenesis of the disease and help us guide disease
activity and severity.
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